Milk biologically active components as nutraceuticals: Review

Critical Reviews in Food Science and Nutrition

Volumn 45, Issue 7-8, 2005, Pages 645-656

  Séverin, Sindayikengera ^a   Wenshui, Xia ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Activity; Oligosaccharides; Peptides; Physiological effects; Proteins

Indexed keywords

MILK PROTEIN;

ANIMAL; CATTLE; CHEMISTRY; FERMENTATION; FOOD HANDLING; HUMAN; MILK; NUTRITIONAL VALUE; REVIEW;

ANIMALS; CATTLE; FERMENTATION; FOOD TECHNOLOGY; HUMANS; MILK; MILK PROTEINS; NUTRITIVE VALUE;

ANIMALIA;

EID: 29344466959     PISSN: 10408398     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408690490911756     Document Type: Review

References (133)

1. Adamson, N.J. and Reynolds, E.G. 1995. Characterization of tryptic casein phosphopeptides prepared under industrially relevant conditions. Biotecluiology and Bioengineering, 45:196-204.
2. Adamson, N.J. and Reynolds, E.G. 1996. Characterization of casein phosphopeptides prepared using alcalase: Determination of enzyme specificity. Enzyme and Microbial Technology, 19:202-207.
3. Aimutis, W.R. 2004. Bioactive properties of milk proteins with particular focus on anticariogenesis. Journal of Nutrition, 134:9898-9958.
4. Antila, P., Paakkari, I., Jarvinen A., Mattila, M.J., Laukkanen, M., Pihlanto-Leppala, A., Mantsala, P., and Hellman, J. 1991. Opioid peptides derived from in vitro proteolysis of bovine whey proteins. International Dairy Journal, 1:215-229.
5. Baker, E.N., Anderson, B.F., Baker, H.M., Day, C.L., Haridas, M., Norris, G.E., Rumball, S.V., Smith, C.A., and Thomas, D.H. 1994. Three-dimensional structure of lactoferrin in various functional states. In: Advances in Experimental Medicine and Biology, pp. 1-12. Hutchens, T.W., Rumball, S.V., and Lönnerdal, B., Eds., Plenum Press, New York.
6. Batish, V.K., Chander, H., Zumdegeni, K.C., Bhatia, K.L., and Singh, R.S. 1988. Antibacterial activity of lactoferrin against some common food-borne pathogenic organisms. Australian Journal of Dairy Technology, 5:16-18.
7. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., and Tomita, M. 1992. Identification of the bactericidal domain of lactoferrin. Biochemica Biophysica. Acta., 1121:130-136.
8. Bicknell, R.S. 1985. Endogenous opioid peptides and hypothalamic neuroendocrine neurons. Scandinavian Endocrinology, 107:43.
9. Bogsted, A.K., Johansen, K., Hatta, R., Kim, M., Casswall, M., Svensson, L., and Hammerström, L. 1996. Passive immunity against diarrhea. Acta. Pediatrica., 85:125-128.
10. Bostwick, E.F., Steijns, J., and Braun, S. 2000. Lactoglobulins. In: Natural food antimicrobial systems, pp. 133-158. Naidu, A. S., Ed., Boca Raton: CRC Press.
11. Brantl, V., Teschemacher, H., Bläíg, J., Henschen, A., and Lottspeich, F. 1981. Opioid activities of β-casomorphins. Life Sciences, 28:1903-1909.
12. Brantl, V., Teschemacher, H., Henschen, A., and Lottspeich, F. 1979. Novel opioid peptides derived from casein (β-casomorphins). Hoppe Seylers Z. Physiol. Chem., 360:1211-1216.
13. Britigan, B.E., Serody, J.S., and Cohen, M.S. 1994. The role of lactoferrin as an anti-inflammatory molecule. In: Advances in Experimental Medicine and Biology, pp. 143-156. Hutchens, T.W., Rumball, S.V., and Lönnerdal, B., Eds., Plenum Press, New York.
14. Brody, E.P. 2000. Biological activities of bovine glycomacropeptide. British Jounrnl of Nutrition, 84:S39-S46.
15. Brommage, R., Juillerat, M.A., and Jost, R. 1991. Influence of casein phosphopeptides and lactulose on intestinal calcium absorption in adult female rats. Lait, 71:173-180.
16. Chang, K.-J., Su, Y.F., and Brent, D.A. 1985. Isolation of a specific μ-Opiate receptor peptide, Morphiceptin, from an enzymatic digest of milk proteins. The Journal of Biological Chemistry, 260:9706-9712.
17. Cheison, S.C. and Wang, Z. 2003. Bioactive milk peptides: Redefining the food-drug interface-Paper 1: Antimicrobial and immunomodulating peptides. Africa Journal of Food, Agriculture, Nutrition and Development, 3:29-38.
18. Chiba, H., Tani, F., and Yoshikawa, M. 1989. Opioid antagonist peptides derived from k-casein. Journal of Dairy Research, 56:363-366.
19. Clare, D.A. and Swaisgood, H.E. 2000. Bioactive milk peptides: A prospectus. Journal of Dairy Science, 83:1187-1195.
20. Coddeville, B., Strecker, G., Wieruszeski, J.M., Vliegenthart, J.F.G., Van Halbeek, H., Peter-Katalinic, J., Egge, H. and Spik, G. 1992. Heterogeneity of bovine lactotransferrin glycans: Characterization of a-D-Galp-(l->3)- β-D-Gal- and α-NeuAc-(2->6)-β-D-GalpNAc-(l->4)-β-D- GlcNAc-substituted N-linked glycans. Carbohydrate Research, 236:145-164.
21. Daniel, H., Vohwinkel, M., and Rehner, G. 1990. Effect of casein and β-casomorphin on gastrointestinal motility in rats. Journal of Nutrition, 120:252-257.
22. Debbabi, H., Dubarry, M., Rautureau, M., and Tomé, D. 1998. Bovine lactoferrin induces both mucosal and systemic immune response in mice. Journal of Dairy Research, 65:283-293.
23. Diarra, M.S., Lacasse, P., and Petitclerc, D. 2001. Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections. International Patent Application No. PCT/CA00/01517.
24. Farrell, H.M.Jr., Jimenez-Flores, R., Bleck, G.T., Brown, E.M., Butler, J.E., Creamer, L.K., Hicks, C. L., Hollar, C.M., Ng-Kwai-Hang, K.F., and Swaisgood, H.E. 2004. Nomenclature of the proteins of cows' milk-Sixth Revision. Journal of Dairy Science, 87:1641-1674.
25. Fiat, A.M., Migliore-Samour, D., Jolles, P., Drouet, I., Bal Dit Soitier, C., and Caen, J. 1993. Biologically active peptides from milk proteins with emphasis on two examples concerning antithrombotic and immunomodulating activities. Journal of Dairy Science, 76:301-310.
26. Fox, P.P. 2001. Milk proteins as food ingredients. International Journal of Diary Technology, 54:41-55.
27. Fox, P.P., and McSweeney, P.L.H. 2001. Advanced Dairy Chemistry: 1. Proteins. 2nd ed., Gaithersburg, MD: Aspen Publishers, Inc.
28. Gobetti, M., Stepaniak, L., De Angelis, M., Corsetti, A., and Di Cagno, R. 2002. Latent bioactive peptides in milk proteins: Proteolytic activation and significance in diary processing. Critical Reviews in Food Science and Nutrition, 42:223-239.
29. Greenberg, R., Groves, M.L., and Dower, H.J. 1984. Human beta-casein. Amino acid sequence and identification of phosphorylation sites. J. Biol. Chem., 259:5132-5138.
30. Grenby, T.H., Andrews, A.T., Mistry, M., and Williams, R.J.H. 2001. Dental caries-protective agents in milk products: Investigations in vitro. Journal of Dentistry, 29:83-92.
31. Hansen, M., Sandström, B., and Lönnerdal, B. 1996. The effect of casein phosphopeptides on zinc and calcium absorption from high phytate infant diets assessed in rat pups and caco-2 cells. Pediatric Research, 40:547-552.
32. Hansen, M., Sandström, B., Jensen, M., and Sörensen, S.S. 1997. Casein phos-phopeptides improve zinc and calcium absorption from rice-based but not from whole-grain infant cereal. Journal of Pediatric Gastroenterology and Nutrition, 24:56-62.
33. Harmsen, M.C., Swart, P.J., DeBéthune, M.P., Pauwels, R., De Clercq, E., Hauw, T., and Meijer, D.K.F. 1995. Antiviral effects of plasma and milk proteins: Lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. Journal of Infectious Diseases, 172:380-388.
34. Haukland, H.H., Ulvatne, H., Sandvik, K., and Vorland, L.H. 2001. The antibacterial peptides lactoferricin B and Magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm. FEBS Lett., 508:389-393.
35. Heany, R.P., Saito, Y., and Orimo, H. 1994. Effect of casein phosphopeptide on absorbability of co-ingested calcium in normal postmenopausal women. Journal of Bone Mineral Metabolism, 12:77-81.
36. Henschen, A., Lottspeich, P., Brantl, V., and Teschemacher, H. 1979. Novel opioid peptides derived from casein, β-casomorphins. II. Structure of active components from bovine casein peptone. Hoppe-Seyler's Physiol. Chem., 360:1217-1224.
37. Hirayama, M., Toyota, K., Hidaka, H., and Naito, H. 1992. Phosphopeptides in rat intestinal digests after ingesting casein phosphopeptides. Bioscience Biotechnology Biochemistry, 56:112-1129.
38. Holt, C. and Horne D.S. 1996. The hairy casein micelle: Evolution of the concept and its implications for dairy technology. Netherlands Milk & Dairy Journal, 50:85-112.
39. Hutchens, T.W., Rumball, S.V., and Lonnerdal, B. 1994. Lactoferrin: Structure and function. Advances in Experimental Medical and Biological, 357:1-298.
40. Jan, M.S. 2001. Milk ingredients as nutraceuticals. International Journal of Dairy Technology, 54:81-88.
41. Jollès, P. 1975. Structural aspects of the milk clotting process. Comparative features with the blood clotting process. Mol. Cell. Biochem., 7:73.
42. Jollès, P., and Menschen, A. 1982. Comparison between the clotting of blood and milk. Trends Biochem. Sci., 7:325.
43. Jollès, P., Loucheux-Lefebvre, M. H., and Hanschen, A. 1978. Structural relatedness of K-casein and fibrinogen y-chain. J. Mol. Evol., 11:271.
44. Jones, E.M., Smart, A., Bloomberg, G., Burgess, L., and Millar, M.R. 1994. Lactoferricin, a new antimicrobial peptide. Journal of Applied Bacteriology, 77:208-214.
45. Kelley, C.P., Chetman, S., Keates, S., Bostwick, E.F., Roush, A.M., Castagliuolo, I., Lamont, J.T., and Pothoulakis, C. 1997. Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract. Antimicrobial Agents and Chemotherapy, 41:236-241.
46. Kelly, P.M., Kelly, J., Mchra, R., Oldfield, D.J., Raggett, E., and O'Kennedy, B.T. 2000. Implementation of integrated membrane processes for pilot scale development of fractionated milk components. Lait, 80:139-153.
47. Kohmura, M., Nio, N., and Ariyoshi, Y. 1990. Inhibition of angiotensin I-converting enzyme by synthetic peptides of human k-casein. Agric. Biol. Chem., 54:835-836.
48. Kohmura, M., Nio, N., Kubo, K., Minoshima, Y., Munekata, E., and Ariyoshi, Y. 1989. Inhibition of angiotensin I-converting enzyme by synthetic peptides of human β-casein. Agrir. Biol. Chem., 53:2107-2114.
49. Korhonen, H. 1977. Antimicrobial factors in bovine colostrum. Journal of the Scientific Agricultural Society of Finland, 49:434-447.
50. Korhonen, H., Pihlanto-Leppala, A., Rantamaki, P., and Tupasela, T. 1998. The functional and biological properties of whey proteins: prospects for the development of functional foods. Agriculture and Food Science in Finland, 7:283-296.
51. Kulkarni, PR., and Pimpale, N.V. 1989. Colostrum-A review. Indian Journal of Dairy Science, 42:216-224.
52. Kussendrager, K. 1993. Lactoferrin and lactoperoxidase: Bioactive milk proteins. International Food Ingredients, 6:17-21.
53. Lahov, E., and Regelson, W. 1996. Antibacterial and immunostimulating caseinderived substances from milk: Caseicidin, isracidin peptides. Food and Chemical Toxicology, 34:131-145.
54. Lee, Y.S., Noguchi, G., and Naito, H. 1980. Phosphopeptides and soluble calcium in the small intestine of rats given a casein diet. British Journal of Nutrition, 43:457-467.
55. Lindsay, S., Paul, N.B., Michael, J.B., Lawrence, K.C., Helen, D., Patrick, J.B.E., Carl, H., Geoffrey, B.J., George, K., Gillian, E.N., Stanislava, U., and Su-Ying, W. 2002. Milk protein structure-What can it tell the dairy industry? International Dairy Journal, 12:299-310.
56. Loukas, L., Varoucha, D., Zioudron, C., Straty, R.A., and Klee, W.A. 1983. Opioid activities and structures of alpha-casein-derived exorphins. Biochemistry, 22:4567-4573.
57. Luo, S.J. and Wong, L.L. 2000. Oral care chewing gums and confections. International Patent Application No. PCT/US00/02142.
58. Maeno, M., Yamamoto, N., and Takano, T. 1996. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus heleveticus CP790. J. Dairy Science, 79:1316-1321.
59. Marchetti, M., Longhi, C., Conte, M.P., Pisani, S., Valenti, P., and Seganti, L. 1977. Lactoferrin inhibits herpes simplex virus type I adsoiption to Vero cells. Antiviral Research, 29:221-231.
60. Maruyama, S., and Suzuki, H. 1982. A peptide inhibitor of angiotensin I-converting enzyme in the tryptic hydrolysate of casein. Agric. Biol. Chem., 46:1393-1394.
61. McIntosh, G.H., Jorgensen, L., and Royle, P.J. 1993. The potential of an insoluble dietary fibre-rich source from barley to protect from DMH-induced intestinal tumors in rats. Nutrition and Cancer, 19:213.
62. McIntosh, G.H., Regester, G.O., Le Leu, R.K., Royle, P.J., and Smithers, G.W. 1995. Dairy proteins protect against dimethylhydrazine-induced intestinal tumors in rats. Journal of Nutrition, 125:809-816.
63. McLeod, A., Fedio, W., Chu, L., and Ozimek, L. 1996. Binding of retionoic acid to β-lactoglobulin variants A and B: Effect of hepatic and tryptic digestion on the protein-ligand complex. Milchwissenschaft, 51:3-7.
64. Meisel, H. 1997. Biochemical properties of regulatory peptides derived from milk proteins. Biopolymers, 43:119-128.
65. Meisel, H. and Frister, H. 1989. Chemical characterization of bio-active peptides from in vivo digests of casein. Journal of Dairy Research, 56:343-349.
66. Meisel, H., Goepfert, A., and Günther, S. 1997. ACE-inhibitory activities in milk products. Milchwissenschaft, 52:307-311.
67. Migliore-Samour, D., Floch, F., and Jolles, P. 1989. Biologically active casein peptides implicated in immunomodulation. Journal of Dairy Research, 56:357.
68. Modler, H.W. 2000. Milk processing. In: Food Proteins: Processing Applications, pp. 1-88. Nakai, S., Modler, H. W., Eds., Willey, New York.
69. Moore, S.A., Anderson, B.F., Groom, C.R., Haridas, M., and Baker, E.N. 1997. Three-dimensional structure of diferric bovine lactoferrin at 2.8 A resolution. Journal of Molecular Biology, 274:222-236.
70. Mullally, M.M., Meisel, H., and Fitzgerald, R.J. 1996. Synthetic peptides corresponding to alpha-lactalbumin and beta-lactoglobulin sequences with angiotensin-I-converting enzyme inhibitory activity. Biological Chemistry Hoppeseyler, 377:259-260.
71. Mullally, M.M., Meisel, H., and Fitzgerald, R.J. 1997. Identification of a novel angiotensin-I-converting enzyme inhibitory peptide corresponding to tryptic fragment of bovine beta-lactoglobulin. FEES Letters, 402:99-101.
72. Nagendra, P.S. 2000. Effects of milk-derived bioactives: An overview. British Journal of Nutrition, 84:S3-S10.
73. Naito, H. and Suzuki, H. 1974. Further evidence for the formation in vivo of phosphopeptide in the intestinal lumen from dietary β-casein. Agricultural and Biological Chemistry, 38:1543-1545.
74. Nakamura, Y., Yamamoto, N., Kumi, S., and Takano, T. 1995. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin-I converting enzyme. Journal of Dairy Science, 78:1253-1257.
75. Newburg, D.S., and Newbauer, S.H. 1995. Carbohydrates in milk. In: Handbook of Milk Composition, pp. 273-349. Jensen, R.G., Ed., Academic Press, San Diego.
76. Newburg, D.S., Pickering, L.K., McCluer, R.H., and Cleary, T.G. 1990. Fucosylated oligosaccharides of human milk protect sucling mice from heat stable enterotoxin of Escherichia coli. Journal of Infectious Diseases, 162:1075-1080.
77. Nibbering, P.H., Ravensbergen, E., Welling, M.M., Van Berkel, L.A., Van Berkel, P.H.C., Pauwels, E.K., and Nuijens, J.H. 2001. Human lactoferrin and peptides derived from its N-Terminus are highly effective against infections with antibiotic resistant bacteria. Infection and Immunity, 69:1469-1476.
78. Pariza, M.W. 1997. Conjugated linoleic acid: A newly recognized nutrient. IFT Annual Meeting, Orlando, FL, Abstract, pp. 15-3.
79. Parker, F., Migliore-Samour, D., Floch, F., Zerial, A., Werner, G.H., Jolles, J., Casaretto, M., Zahn, H., and Jolles, P. 1984. Immunostimulating hexapeptide from human casein: Amino acid sequence, synthesis, and biological properties. European Journal of Biochemistry, 145:677.
80. Paroli, E. 1988. Opioid peptides from food (the exorphins). World Rev. Nutr. Diet, 55:58-97.
81. Payne, K.D., Davidson, P.M., and Oliver, S.P. 1990. Influence of bovine lactoferrin on the growth of Listeria monocytogenes. Journal of Food Protection, 53:468-472.
82. Petrilli, P., Addeo, F., and Chianese L. 1983. Primary structure of water buffalo beta-casein tryptic and CNBr peptides. Ital. J. Biochem., 32:336-344.
83. Pierce, A., Colavizza, D., Benaissa, M., Maes, P., Tartra, A., Montreuil, J., and Spik, G. 1991. Molecular cloning and sequence analysis of bovine lactoferrin. European Journal of Biochemistry, 196:177-184.
84. Pihlanto-Leppälä, A. 2001. Bioactive peptides derived from bovine whey proteins: Opioid and ACE-Inhibitory peptides. Trends in Food Science & Technology, 11:347-356.
85. Pihlanto-Leppala, A., Antila, P., Mantsala, P., and Hellamn, J. 1994. Opioid peptides produced by in vivo proteolysis of bovine caseins. Int. Dairy J., 4:291-301.
86. Pointillart, A. and Gueguen, L. 1989. Effect of casein phosphopeptides on calcium and phosphorous utilization in growing pigs. Reproduction Nutrition Development, 29:477-486.
87. Reddy, N.R., Roth, S.M., Eigel, W.N., and Pierson, M.D. 1988. Foods and food ingredients for prevention of diarrheal disease in children in developing countries. Journal of Food Protection, 51:66-75.
88. Regester, G.O., McIntosh, G.H., Lee, V.W.K., and Smithers, G.W. 1996. Whey proteins as nutritional and functional food ingredients. Food Australia, 48:123-126.
89. Reynolds, E.C., Riley, P.F., and Adamson, N.J. 1994. A selective purification precipitation procedure for multiple phosphoseryl-containing peptides and methods for their identification. Anal. Biochem., 217:277-284.
90. Richardson, B.C. and Mercier, J.C. 1979. The primary structure of the ovine beta-caseins. Eur. J. Biochem., 99:285-297.
91. 15N-labelled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. Journal of Nutrition, 125:1238-1244.
92. Saito, H., Miyakawa, H., Tamura, Y., Shimamura, S., and Tomita, M. 1991. Potent bacteriocidal activity of bovine lactoferrin hydrolysate reproduced by heat treatment at acidic pH. Journal of Dairy Science, 74:3724-3730.
93. Sakai, M., Kobayashi, M., and Yoshida, T. 1995. Activation of rainbow trout, Oncorhynchus mykiss, phagocytic cells by administration of bovine lactoferrin. Comparative Biochemistry and Physiology, 110B:755-759.
94. Sato, R., Inanami, O., Tanak, Y., Takase, M., and Naito, Y 1996. Oral administration of bovine lactoferrin for treatment of intractable stomatitis in feline immunodeficiency virus (FIV)-positive and FIV-negative cats. American Journal of Veterinary Research, 57:1443-1446.
95. Sato, R., Noguchi, T., and Naito, H. 1986. Casein phosphopeptide (CPP) enhances calcium absorption from the ligated segment of rat small intestine. Journal of Nutrition Science and Vitaminology, 32:67-76.
96. Schlimme, E. and Meisel, H. 1995. Bioactive peptides derived from milk proteins: Structural, physiological, and analytical aspects. Die Nahrung, 39:1-20.
97. Schmelz, E.M. and Merrill, A.M. 1997. Milk sphingolipids: A new category of functional food. IFT Annual Meeting, Orlando, FL, Abstract, pp. 15-4.
98. Scholz-Ahrens, K.E. and Schrezenmeir, J. 2000. Effects of bioactive substances in milk on mineral and trace element metabolism with special reference to casein phosphopeptides. British Journal of Nutrition, 84:S147-S153.
99. Scholz-Ahrens, K.E., Kopra, N., and Earth, C.A. 1990. Effect of casein phos-phopeptides on utilization of calcium in minipigs and vitamin-D deficient rats. Zeitschrift für Ernährungswissenschaft, 29:295-298.
100. Sekiya, S., Kobayashi, Y., Kita, E., Imamura, Y., and Toyama, S. 1996. Antihypeitensive effects of tryptic hydrolysates of casein on normotensive and hypertensive volunteers. Journal of Japanese Society of Nutrition and Food Science, 45:513.
101. Seppo, L., Jauhiainen, T., Poussa, T., and Korpela, R. 2003. A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr., 77:326-330.
102. Shin, K., Yamauchi, K., Teraguchi, S., Hayasawa, H., Tomita, M., Otsuka, Y., and Yamazaki, S. 1998. Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli 0157:H7. Letters on Applied Microbiology, 6:407-411.
103. Silva. H.E.R. and Verdalet, G.I. 2003. Functional foods and ingredients derived from milk. Arch. Latinoam. Nutr., 53:333-347.
104. Smacchi, E. and Gobbetti, M. 2000. Bioactive peptides in dairy products: Synthesis and interaction with proteolytic enzyme. Food Microbiology, 17:129-141.
105. Spik, G., Coddeville, B., Mazurier, J., Bourne, Y., Cambillaut, C., and Montreuil, J. 1994. Primary and three-dimensional structure of lactotransferrin (lactoferrin) glycans. In: Advances in Experimental Medicine and Biology, pp. 21-32. Hutchens, T.W., Rumball, S.V., and Lönnerdal, B., Eds., Plenum Press, New York.
106. Steijns, J.M. and Van Hooijdonk, A.C.M. 2000. Occurrence, structure, biochemical properties and technological characteristics of lactoferrin. British Journal of Nutrition, 84:S1-S8.
107. Superti, F., Ammendolia, M.G., Valenti, P., and Seganti, I. 1997. Antirotaviral activity of milk proteins: Lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Medical Microbiology and Immunology, 186:83-91.
108. Suzuki, T., Yamauchi, K., Kawase, K., Tomita, M., Kiyasawa, I., and Okongi, S. 1989. Collaborative bacteriostatic activity of bovine lactoferrin with lysozyme against E. coli 0111. Agriculture and Biological Chemistry, 53:1705-1706.
109. Svedberg, J., De Haas, J., Leimenstoll, G., Paul, F., and Teschemacher, H. 1985. Demonstration of β-casomorphin immunoreactive materials in in vivo digests of bovine milk and in small intestine contents after bovine milk ingestion in adults humans. Peptides, 6:625.
110. Tani, F., Iio, K., Chiba, H., and Yoshikawa, M. 1990. Isolation and characterization of opioid antagonist peptides derived from human lactoferrin. Agr: Biol. Chem., 54:1803-1810.
111. Tani, F., Shiota, H., Chiba, H., and Yoshikawa, M. 1994. Serophin, an opioid peptide derived from serum albumin. In: β-Casomorphins and related peptides: Recent developments, pp. 49-53. Brantl, V. and Teschemacher, H., Eds., VCH-Weinheim, Germany.
112. Tomita, M., Bellamy, W.R., Takase, M., Yamauchi, K., Wakabayashi, H., and Kawase, K. 1991. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. Journal of dairy Science, 74:4137-4142.
113. Tsuchita, H., Goto, T., Shimizu, T., Yonehara, Y., and Kuwata, T. 1996. Dietary casein phosphopeptides prevent bone loss in aged ovariectomized rats. Journal of Nutrition, 126:86-93.
114. Tsuchita, H., Suzuki, T., and Kuwata, T. 2001. The effect of casein phospho-peptides on calcium absorption from calcium-fortified milk in growing rats. British Journal of Nutrition, 85:5-10.
115. Tsuji, S., Hirata, Y., Mukai, F., and Ohtagaki, S. 1990. Comparison of lactoferrin content in colostrum between different cattle breeds. Journal of Dairy Science, 73:125-128.
116. Van der Meer, R. and Lapre, J.A. 1991. Calcium and colon cancer. Bulletin of the International Dairy Federation, 255:55-59.
117. Van der Ven, C. 2002. Biochemical and functional characterization of casein and whey protein hydrolysates. A study on the correlations between biochemical and functional properties using multivariate data analysis. Ph.D thesis, Wageningen University, The Netherlands.
118. Vannini, L., Lanciotti, R., Baldi, D., and Guerzoni, M.E. 2004. Interactions between high pressure homogenization and antimicrobial activity of lysozyme and lactoperoxidase. International Journal of Food Microbiology, 94:123-135.
119. Viljoen, M. 1995. Lactoferrin: A general review. Haematologica, 80:252-267.
120. Visalsok, T., Shigeru, H., Satoshi, Y., and Souichi, K. 2004. Effects of a lactoperoxidase-thiocyanate-hydrogen peroxide system on Salmonella enteritidis in animal or vegetable foods. International Journal of Food Microbiology, 93:175-183.
121. Walstra, P. and Jenness, R. 1984. Dairy chemistry and physics. John Willey & Sons, Inc., New York.
122. Walzern, R.L., Dillard, C.J., and German, J.B. 2002. Whey components: Millennia of evolution create functionalities for mammalian nutrition: What we know and what we may be overlooking. Critical Reviews in Food Science and Nutrition, 42:353-375.
123. Warner, E. A., Kanekanian, A.D., and Andrews, A.T. 2001. Bioactivity of milk proteins: 1. Anticariogenicity of whey proteins. International Journal of Dairy Technology, 54:151-153.
124. Weiner, C., Pan, Q., Hurtif, M., Boren, T., Bostwick, E., and Hammerstrom, L. 1999. Passive immunity against human pathogens using bovine antibodies. Clinical Experimental Immunology, 116:193-205.
125. Wong, C.W. and Watson, D.L. 1995. Immunomodulatory effects of dietary whey proteins in mice. Journal of Dairy Research, 62:359-368.
126. Wu, J.P. and Ding, X.L. 2002. Characterization of inhibitory and stability of soy protein-derived Angiotensin-I-Converting Enzyme inhibitory peptides. Food Research International, 35:367-375.
127. Yamauchi, K. 1992. Biologically functional proteins of milk and peptides derived from milk proteins. Bulletin of the International Dairy Federation, 272:51.
128. Yen, S.S.C., Quingley, M.E., Reid R.L., Ropert, J.F., and Cetei, N.S. 1985. Neuroendocrinology of opioid peptides and their role in the control of gonadotrophin and prolactin secretion. American Journal of Obstetrics and Gynaecology, 152:485.
129. Yolken, R.H., Peterson, J.A., Vonderfech, S.L., Fouts, E.T., Midthun, K., and Newburg, D.S. 1991. Human milkmucin inhibits rotavirus replication and prevents experimental gastroenteritis. Journal of Clinical Investigation, 90:1984-1991.
130. Yoshikawa, M., Tani, F., Yoshimura, T., and Chiba, H. 1986. Opioid peptides from milk protein. Agric. Biol. Chem., 50:2419-2421.
131. Yoshikawa, M., Yoshimura, T., and Chiba, H. 1984. Opioid peptides from human β-casein. Agric. Biol. Chem., 48:3185-3187.
132. Yuan, Y.V. and Kitts, D.D. 1991. Confirmation of calcium absorption and femoral utilization in spontaneously hypertensive rats fed casein phosphopeptide diets. Nutrition Research, 11:1257-1272.
133. Zioudrou, C., Streaty, R.A., and Klee, W.A. 1979. Opioid peptides derived from food. The exorphins. J. Biol. Chem., 254:2446-2449.